Heart drug tested in fight against ALS nerve damage
NCT ID NCT07047209
Summary
This trial is testing if digoxin, an FDA-approved heart medication, is safe and tolerable for people with early ALS (within 2 years of symptoms). It will also check if the drug can slow the progression of nerve damage by measuring a specific blood protein. The study involves 40 participants who will take the oral drug for 24 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALS (AMYOTROPHIC LATERAL SCLEROSIS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
MGH
Boston, Massachusetts, 02114, United States
-
Northwestern Universsity
Chicago, Illinois, 60611, United States
-
Nova Southeastern University
Davie, Florida, 33314, United States
Conditions
Explore the condition pages connected to this study.